tetano
Editor, Senior Moderator
Aging (Albany NY)
. 2020 Jun 24;12(12):11245-11258.
doi: 10.18632/aging.103372. Epub 2020 Jun 24.
Lactate Dehydrogenase, an Independent Risk Factor of Severe COVID-19 Patients: A Retrospective and Observational Study
Yi Han[SUP] 1 [/SUP], Haidong Zhang[SUP] 2 [/SUP], Sucheng Mu[SUP] 1 [/SUP], Wei Wei[SUP] 1 [/SUP], Chaoyuan Jin[SUP] 1 [/SUP], Chaoyang Tong[SUP] 1 [/SUP], Zhenju Song[SUP] 1 [/SUP], Yunfei Zha[SUP] 2 [/SUP], Yuan Xue[SUP] 1 [/SUP], Guorong Gu[SUP] 1 [/SUP]
Affiliations
Abstract
Background: The World Health Organization has declared coronavirus disease 2019 (COVID-19) a public health emergency of global concern. Updated analysis of cases might help identify the risk factors of illness severity.
Results: The median age was 63 years, and 44.9% were severe cases. Severe patients had higher APACHE II (8.5 vs. 4.0) and SOFA (2 vs. 1) scores on admission. Among all univariable parameters, lymphocytes, CRP, and LDH were significantly independent risk factors of COVID-19 severity. LDH was positively related both with APACHE II and SOFA scores, as well as P/F ratio and CT scores. LDH (AUC = 0.878) also had a maximum specificity (96.9%), with the cutoff value of 344.5. In addition, LDH was positively correlated with CRP, AST, BNP and cTnI, while negatively correlated with lymphocytes and its subsets.
Conclusions: This study showed that LDH could be identified as a powerful predictive factor for early recognition of lung injury and severe COVID-19 cases.
Methods: We extracted data regarding 107 patients with confirmed COVID-19 from Renmin Hospital of Wuhan University. The degree of severity of COVID-19 patients (severe vs. non-severe) was defined at the time of admission according to American Thoracic Society guidelines for community acquired pneumonia.
Keywords: COVID-19; coronavirus disease 2019; inflammatory response; lactate dehydrogenase (LDH); lung injury.
. 2020 Jun 24;12(12):11245-11258.
doi: 10.18632/aging.103372. Epub 2020 Jun 24.
Lactate Dehydrogenase, an Independent Risk Factor of Severe COVID-19 Patients: A Retrospective and Observational Study
Yi Han[SUP] 1 [/SUP], Haidong Zhang[SUP] 2 [/SUP], Sucheng Mu[SUP] 1 [/SUP], Wei Wei[SUP] 1 [/SUP], Chaoyuan Jin[SUP] 1 [/SUP], Chaoyang Tong[SUP] 1 [/SUP], Zhenju Song[SUP] 1 [/SUP], Yunfei Zha[SUP] 2 [/SUP], Yuan Xue[SUP] 1 [/SUP], Guorong Gu[SUP] 1 [/SUP]
Affiliations
- PMID: 32633729
- DOI: 10.18632/aging.103372
Abstract
Background: The World Health Organization has declared coronavirus disease 2019 (COVID-19) a public health emergency of global concern. Updated analysis of cases might help identify the risk factors of illness severity.
Results: The median age was 63 years, and 44.9% were severe cases. Severe patients had higher APACHE II (8.5 vs. 4.0) and SOFA (2 vs. 1) scores on admission. Among all univariable parameters, lymphocytes, CRP, and LDH were significantly independent risk factors of COVID-19 severity. LDH was positively related both with APACHE II and SOFA scores, as well as P/F ratio and CT scores. LDH (AUC = 0.878) also had a maximum specificity (96.9%), with the cutoff value of 344.5. In addition, LDH was positively correlated with CRP, AST, BNP and cTnI, while negatively correlated with lymphocytes and its subsets.
Conclusions: This study showed that LDH could be identified as a powerful predictive factor for early recognition of lung injury and severe COVID-19 cases.
Methods: We extracted data regarding 107 patients with confirmed COVID-19 from Renmin Hospital of Wuhan University. The degree of severity of COVID-19 patients (severe vs. non-severe) was defined at the time of admission according to American Thoracic Society guidelines for community acquired pneumonia.
Keywords: COVID-19; coronavirus disease 2019; inflammatory response; lactate dehydrogenase (LDH); lung injury.